FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2063767851> ?p ?o ?g. }

• W2063767851 endingPage "99" @default.
• W2063767851 startingPage "92" @default.
• W2063767851 abstract "Objective: The purpose of this study was to compare the effects on vaginal bleeding patterns of continuous combined hormone replacement therapy with norethindrone acetate and ethinyl estradiol versus conjugated equine estrogens and medroxyprogesterone acetate. Study Design: Three hundred fifty-seven postmenopausal women were selected randomly (in a blinded manner) to 12 months of treatment with 1 mg norethindrone acetate/5 μg ethinyl estradiol, placebo, or open-label 0.625 mg conjugated equine estrogens/2.5 mg medroxyprogesterone acetate (conjugated equine estrogens/medroxyprogesterone acetate [CEE/MPA]; Prempro). The incidence and duration of vaginal bleeding were assessed throughout the study. Statistical analyses used Cochran-Mantel-Haenszel methodology and analysis of variance. Results: At 3 months, 1 mg norethindrone acetate/5 μg ethinyl estradiol therapy reduced the incidence of bleeding (12% vs 23%; P < .029) and bleeding and/or spotting (22% vs 44%; P < .001), compared with conjugated equine estrogens/medroxyprogesterone acetate therapy. The mean duration of bleeding and bleeding and/or spotting were also reduced with 1 mg norethindrone acetate/5 μg ethinyl estradiol therapy versus conjugated equine estrogens/medroxyprogesterone acetate (P = .004 and P < .001, respectively). The incidence of cumulative amenorrhea at every monthly interval was significantly better with 1 mg norethindrone acetate/5 μg ethinyl estradiol therapy versus conjugated equine estrogens/medroxyprogesterone acetate therapy (P < .05). Associated adverse event (ie, headache, breast pain) incidence rates were similar in the 2 active treatment groups. Conclusion: The 1 mg norethindrone acetate/5 μg ethinyl estradiol therapy provides significantly better control of vaginal bleeding than conjugated equine estrogens/medroxyprogesterone acetate therapy at all time points investigated in this 12-month study. (Am J Obstet Gynecol 2003;188:92-9.)" @default.
• W2063767851 created "2016-06-24" @default.
• W2063767851 creator A5028401969 @default.
• W2063767851 creator A5049914184 @default.
• W2063767851 creator A5060607282 @default.
• W2063767851 creator A5079180373 @default.
• W2063767851 creator A5091296451 @default.
• W2063767851 date "2003-01-01" @default.
• W2063767851 modified "2023-09-25" @default.
• W2063767851 title "Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy" @default.
• W2063767851 cites W1970085552 @default.
• W2063767851 cites W1979252773 @default.
• W2063767851 cites W1992775082 @default.
• W2063767851 cites W2007418011 @default.
• W2063767851 cites W2009670845 @default.
• W2063767851 cites W2027533383 @default.
• W2063767851 cites W2029180490 @default.
• W2063767851 cites W2031570803 @default.
• W2063767851 cites W2042568905 @default.
• W2063767851 cites W2067372612 @default.
• W2063767851 cites W2094008928 @default.
• W2063767851 cites W2098533587 @default.
• W2063767851 cites W2100014281 @default.
• W2063767851 cites W2144238512 @default.
• W2063767851 cites W2147569464 @default.
• W2063767851 cites W2179632721 @default.
• W2063767851 cites W2399189465 @default.
• W2063767851 doi "https://doi.org/10.1067/mob.2003.104" @default.
• W2063767851 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12548201" @default.
• W2063767851 hasPublicationYear "2003" @default.
• W2063767851 type Work @default.
• W2063767851 sameAs 2063767851 @default.
• W2063767851 citedByCount "27" @default.
• W2063767851 countsByYear W20637678512012 @default.
• W2063767851 countsByYear W20637678512015 @default.
• W2063767851 countsByYear W20637678512017 @default.
• W2063767851 countsByYear W20637678512018 @default.
• W2063767851 countsByYear W20637678512020 @default.
• W2063767851 countsByYear W20637678512021 @default.
• W2063767851 countsByYear W20637678512022 @default.
• W2063767851 crossrefType "journal-article" @default.
• W2063767851 hasAuthorship W2063767851A5028401969 @default.
• W2063767851 hasAuthorship W2063767851A5049914184 @default.
• W2063767851 hasAuthorship W2063767851A5060607282 @default.
• W2063767851 hasAuthorship W2063767851A5079180373 @default.
• W2063767851 hasAuthorship W2063767851A5091296451 @default.
• W2063767851 hasConcept C126322002 @default.
• W2063767851 hasConcept C134018914 @default.
• W2063767851 hasConcept C2775934596 @default.
• W2063767851 hasConcept C2776306185 @default.
• W2063767851 hasConcept C2777164284 @default.
• W2063767851 hasConcept C2777687323 @default.
• W2063767851 hasConcept C2779076696 @default.
• W2063767851 hasConcept C2779234561 @default.
• W2063767851 hasConcept C2779279991 @default.
• W2063767851 hasConcept C2780159708 @default.
• W2063767851 hasConcept C2780218171 @default.
• W2063767851 hasConcept C2908647359 @default.
• W2063767851 hasConcept C2986817661 @default.
• W2063767851 hasConcept C54355233 @default.
• W2063767851 hasConcept C71924100 @default.
• W2063767851 hasConcept C86803240 @default.
• W2063767851 hasConcept C99454951 @default.
• W2063767851 hasConceptScore W2063767851C126322002 @default.
• W2063767851 hasConceptScore W2063767851C134018914 @default.
• W2063767851 hasConceptScore W2063767851C2775934596 @default.
• W2063767851 hasConceptScore W2063767851C2776306185 @default.
• W2063767851 hasConceptScore W2063767851C2777164284 @default.
• W2063767851 hasConceptScore W2063767851C2777687323 @default.
• W2063767851 hasConceptScore W2063767851C2779076696 @default.
• W2063767851 hasConceptScore W2063767851C2779234561 @default.
• W2063767851 hasConceptScore W2063767851C2779279991 @default.
• W2063767851 hasConceptScore W2063767851C2780159708 @default.
• W2063767851 hasConceptScore W2063767851C2780218171 @default.
• W2063767851 hasConceptScore W2063767851C2908647359 @default.
• W2063767851 hasConceptScore W2063767851C2986817661 @default.
• W2063767851 hasConceptScore W2063767851C54355233 @default.
• W2063767851 hasConceptScore W2063767851C71924100 @default.
• W2063767851 hasConceptScore W2063767851C86803240 @default.
• W2063767851 hasConceptScore W2063767851C99454951 @default.
• W2063767851 hasIssue "1" @default.
• W2063767851 hasLocation W20637678511 @default.
• W2063767851 hasLocation W20637678512 @default.
• W2063767851 hasOpenAccess W2063767851 @default.
• W2063767851 hasPrimaryLocation W20637678511 @default.
• W2063767851 hasRelatedWork W1969337072 @default.
• W2063767851 hasRelatedWork W1985788317 @default.
• W2063767851 hasRelatedWork W2020796252 @default.
• W2063767851 hasRelatedWork W2040601908 @default.
• W2063767851 hasRelatedWork W2063767851 @default.
• W2063767851 hasRelatedWork W2071866325 @default.
• W2063767851 hasRelatedWork W2083030277 @default.
• W2063767851 hasRelatedWork W2108980296 @default.
• W2063767851 hasRelatedWork W2161469520 @default.
• W2063767851 hasRelatedWork W2465917459 @default.
• W2063767851 hasVolume "188" @default.
• W2063767851 isParatext "false" @default.
• W2063767851 isRetracted "false" @default.

• next